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Abstract
We recently identified three novel thioredoxin-like genes in the genome of the protozoan
parasite Plasmodium that belong to the Phosducin-like family of proteins (PhLP). PhLPs are
small cytosolic proteins hypothesized to function in G-protein signaling and protein folding.
Although PhLPs are highly conserved in eukaryotes from yeast to mammals, only a few rep-
resentatives have been experimentally characterized to date. In addition, while PhLPs con-
tain a thioredoxin domain, they lack a CXXC motif, a strong indicator for redox activity, and it
is unclear whether members of the PhLP family are enzymatically active. Here, we describe
PbPhLP-3 as the first phosducin-like protein of a protozoan organism, Plasmodium berghei.
Initial transcription analysis revealed continuous low-level expression of pbphlp-3 through-
out the complex Plasmodium life cycle. Attempts to knockout pbphlp-3 in P. berghei did not
yield live parasites, suggesting an essential role for the gene in Plasmodium. We cloned,
expressed and purified PbPhLP-3 and determined that the recombinant protein is redox
active in vitro in a thioredoxin-coupled redox assay. It also has the capacity to reduce the
organic compound tert-Butyl hydroperoxide (TBHP) in vitro, albeit at low efficiency. Se-
quence analysis, structural modeling, and site-directed mutagenesis revealed a conserved
cysteine in the thioredoxin domain to be the redox active residue. Lastly, we provide evi-
dence that recombinant human PhLP-3 exhibits redox activity similar to that of PbPhLP-3
and suggest that redox activity may be conserved in PhLP-3 homologs of other species.
Our data provide new insight into the function of PhLP-3, which is hypothesized to act as co-
chaperones in the folding and regulation of cytoskeletal proteins. We discuss the potential
implications of PhLP-3 as a thioredoxin-target protein and possible links between the cellular
redox network and the eukaryotic protein folding machinery.
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Introduction
Thioredoxins (Trx) and thioredoxin-like proteins (Tlp) are small ubiquitous proteins present
throughout the tree of life. The members of the Trx-superfamily contain at least one Trx-
domain, which forms a characteristic compact 3D structure known as the Trx-fold with a cen-
tral twisted beta-sheet sandwiched by at least three alpha helices [1–3]. Some Trx and Tlps
exhibit thiol-based redox activity facilitated by a [-CXXC-] active site motif located in the Trx-
domain. A prominent example is the canonical Trx-1, a highly conserved cytosolic protein
that contains a [-CGPC-] active site motif and functions as a cellular master redox regulator
[3]. As such, Trx-1 has multiple target proteins in a variety of cellular pathways, such as antiox-
idant defense, nucleotide biosynthesis, transcription factors, and protein folding. For Trx-1 to
be active it needs to be in its reduced state (Trx(SH)2). Trx-1 is supplied with reducing equiva-
lents by NADPH via the flavoenzyme thioredoxin reductase (TrxR). Together TrxR and Trx-1
form the Trx-system of a cell (Fig 1).
The protozoan parasite Plasmodium belongs to the phylum Apicomplexa and is the causa-
tive agent of the infectious disease Malaria. The parasite is transmitted between people by
Anopheles mosquitoes. Initial studies of the Trx-system in Plasmodium focused on its role in
antioxidant defense and parasite survival [4, 5]. One goal of these studies was to identify poten-
tial anti-malarial drug targets [6, 7]. Over time, new roles for the Trx-system were described as
more Trx and Tlps were identified in the genomes of various Plasmodium species [7]. Studies
have now expanded from the disease causing blood stages of Plasmodium in the human host
to the developmental stages of the parasite inside the mosquito vector. Yet, our understanding
of Plasmodium cell biology in the mosquito is still very limited. Plasmodium berghei is a promi-
nent model organism for the study of malaria in mice and in mosquitoes [8].
More than fifty genes in the P. berghei genome are currently annotated as putative Trx or
Tlp due to the presence of a predicted Trx-domain. Those that have been experimentally
characterized [6, 7] are implemented in diverse cellular pathways, including nucleotide metab-
olism, antioxidant defense, redox signaling and red blood cell invasion [9]. We recently deter-
mined that three of the predicted Trx-domain containing genes belong to the phosducin
family of proteins (PhLP) [10]. PhLPs are highly conserved from yeast to mammals [11, 12]
and these Plasmodium genes represent the first identified in a protozoan organism [10].
PhLPs represent a family of small Trx-domain containing proteins that exhibit the same
basic structural organization consisting of an N-terminal helix domain followed by a Trx-
domain and a short C-terminus [11]. Unlike Trx-1, however, PhLPs do not possess the charac-
teristic [CXXC] active site and are therefore considered not to be redox active [13, 14]. The
increasing number of PhLPs described in diverse organisms led to the formation of three
PhLP-subfamilies organized with respect to sequence homology and putative cell function
Fig 1. The central role of the thioredoxin system and its target proteins. The flavoenzyme thioredoxin reductase (TrxR) and the small redox-active
thioredoxin (Trx-1) constitute the Trx-system, which supplies reducing equivalents to Trx-target proteins that are involved in various cellular
processes.
https://doi.org/10.1371/journal.pone.0209699.g001
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[13]. Members of the PhLP-1 subfamily are closely related to the canonical phosducins (or
PDCs), which were originally identified in mammalian retina rod photoreceptor cells where
they function in trimeric G-protein signaling [12]. Members of the PhLP-2 and PhLP-3 sub-
families are both hypothesized to play roles as co-chaperones via the formation of a ternary
complex with the chaperonin-containing t-complex polypeptide 1 (CCT) [15]. However, the
biochemical properties of these highly conserved proteins remain unclear.
Here we report on the characterization of PbPhLP-3, of the protozoan parasite P. berghei.
We first determined the transcription profile of pbphlp-3 during parasite development in the
mouse host and during early development in the mosquito. We then made an attempt to disrupt
the gene in P. berghei. We cloned, expressed and purified PbPhLP-3 for initial biochemical char-
acterization and tested its potential redox activity in vitro. Lastly, based on the high sequence
and structural homology between Plasmodium and human PhLP-3 (HsPhLP-3; thioredoxin-
domain containing protein 9 (TXNDC9)) we cloned, expressed and purified the HsPhLP-3 and
investigated the potential conservation of redox activity within the PhLP-3 subfamily.
Results
Organization of the P. berghei PhLP family
We previously identified three putative Trx-like genes in the genome of the rodent malaria
parasite P. berghei as members of the phosducin-like family of proteins (PhLP), specifically
PBANKA_1204800, PBANKA_0519700, and PBANKA_1231200 [10, 16]. PBANKA_1204800
was designated as PhLP-1 as it was the first PhLP we identified in a Plasmodium species [10].
However, re-analysis of sequence data from multiple organisms suggests that PBANKA_1204800
belongs to the PhLP-3 subgroup, while PBANKA_1231200 is more closely related to the PhLP-1
subgroup [S1 Fig]. The annotation of PBANKA_0519700 as PhLP-2 was confirmed. Conse-
quently, for the remainder of this report, we will refer to the members of the P. berghei PhLP
family as follows: PBANKA_1231200 as PbPhLP-1, PBANKA_0519700 as PbPhLP-2, and
PBANKA_1204800 as PbPhLP-3 (Table 1). Here we report on the characterization of PbPhLP-3,
which shows the highest conservation among eukaryotes.
pbphlp-3 is constitutively expressed
Analysis of transcriptome and proteome data sets on PlasmoDB revealed that phlp-3 is actively
transcribed by P. berghei and other Plasmodium species, including the human pathogens
Table 1. PhLP in P. berghei.
P. berghei PhLP family PbPhLP-1 PbPhLP-2 PbPhLP-3
NCBI Accession # CDS49513.1 CDS45324.1 SCO63514.1
PlasmoDB Gene ID PBANKA_1231200 PBANKA_0519700 PBANKA_1204800
Genomic Location (chr:position) 12: 1204764–1205699 5: 707940–709565 12: 201652–202233
# of Exons 1 8 1
Length (AA) 311 213 193
P. falciparum ortholog identity 64.1% 68.57% 75.13%
# of Trx Domains 2 1 1
Previous Alias/ID PbPhLP-3 PbPhLP-2 PbPhLP-1
Transcriptome [17, 18] all stages� blood stages� all stages�
Proteome [17, 19] gametocytes N/A sporozoites, gametocytes
Putative function N/A N/A cell redox homeostasis
Phenotype N/A non-essential [20] Essential [this report]
https://doi.org/10.1371/journal.pone.0209699.t001
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P. falciparum and P. vivax (Table 1). We first confirmed expression of pbphlp-3 in P. berghei
utilizing quantitative real time-RT PCR (RT-qPCR). Transcript abundance was determined
for pbphlp-3 (S1 Fig and S2 Fig) and two control genes of the Trx-superfamily, thioredoxin-
dependent peroxiredoxin-1 (tpx-1; PBANKA_1302800) and 1-cysteine peroxiredoxin (1-cys prx;
PBANKA_122800) [21]. pbphlp-3 expression in P. berghei was confirmed in samples taken
from infected mouse blood containing mixed asexual stages (Fig 2A). The level of pbphlp-3
transcription was low and comparable to that of the control gene 1-cys prx. In comparison, the
RNA level of tpx-1 was significantly higher (10.6 fold), which is due to its antioxidant function
during blood stage development of the parasite. The expression of both control genes during
parasite development in mammalian blood is consistent with recent reports [21–23].
We next investigated whether pbphlp-3 expression was maintained during parasite develop-
ment in the mosquito. To this end, we dissected bloodfed midguts from mosquitoes 12 hours
after they were allowed to feed on P. berghei-infected mice. Our data show that low pbphlp-3
expression persisted during parasite development in the mosquito (Fig 2B) as both control
genes showed significantly higher expression levels, with pbtpx-1 16-fold higher, and 1-cys prx
20-fold higher than the pbphlp-3 transcript (Fig 2B). The increased expression of the control
genes was expected as the parasites responds to the hostile conditions in the mosquito blood-
meal [21]. Consequently, when mosquito-stage parasites were allowed to develop under cul-
ture conditions, in the absence of the bloodmeal environment, the control genes were not
upregulated and expression levels of all three genes showed no significant differences (Fig 2B).
This indicates that the midgut environment in the blood meal has no impact on pbphlp-3
expression. To test this, we determined pbphlp-3 transcription profiles in parasites developing
within mosquito midguts or in culture. No significant modulation of pbphlp-3 expression was
detected in blood meal derived or in culture-derived parasites of the recorded time (Fig 2C).
This indicates that pbphlp-3 expression is largely independent of external challenges in the
mosquito midgut. Taken together, our data suggest continuous but low-level pbphlp-3 expres-
sion in parasites from the mouse blood as well as from bloodfed mosquitoes. No stage-specific
or environmentally induced upregulation was observed during the investigated parasite stages.
Fig 2. Relative expression of pbphlp-3 in different parasite stages. Relative transcript abundance of pbphlp-3 and the control genes thioredoxin-dependent peroxidase-1
(tpx-1) and 1-cys peroxiredoxin (1-cys prx) in A. asexual P. berghei parasites from mouse blood B. mosquito stage parasites developing either in the mosquito midgut or
under culture condition. Indicated fold changes specify the difference to pbphlp-3 expression. �� signify statistical significance with a p-value<0.05. C. Temporal
transcription profile of pbphlp-3 in developing mosquito-stage parasites during the first 24 hours in mosquito midguts or under culture conditions, respectively. For the
investigation of mosquito stage parasites female mosquitoes were allowed to feed on infected mice and blood fed midguts were subsequently dissected at 3, 6, 12, and 24
hours post blood meal. For ookinete cultures, samples were taken at the same time points as the midgut dissections. Error bars represent standard deviation of three
independent experiments.
https://doi.org/10.1371/journal.pone.0209699.g002
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pbphlp-3 is essential for Plasmodium
Our next goal was to knock out pbphlp-3 in the rodent parasite. pbphlp-3 is a single-copy,
single-exon gene located on chromosome 12 in the P. berghei genome (Table 1). The open
reading frame (orf) spans 582 base pairs and codes for a 193 amino acid protein (S1 Fig). A
targeting plasmid was constructed to replace the protein-coding region of pbphlp-3 with a T.
gondii dhfr/ts selection cassette, which confers to transfected parasites resistance to the antima-
larial drug pyrimethamine (pyr) (Fig 3 and S2 Fig). Following transfection of the plasmid into
isolated blood stages of wild-type (WT) P. berghei the parasites were immediately injected into
the tail-veins of naïve mice [24]. Mice were provided with pyr treated drinking water and their
blood was frequently checked for drug resistant parasites. A total of four successive trials was
conducted. Following each transfection, neither viable pyr–resistant integrated parasites, nor
viable parasites maintaining episomes could be obtained. Positive control transfections per-
formed in parallel successfully generated viable drug-resistant parasites [25]. Based on these
results we conclude that pbphlp-3 is likely to be essential for P. berghei blood stages.
Conservation of PhLP-3 sequence, organization, and structure
Our failed knockout attempts suggest an important role for pbphlp-3 in the parasite. We there-
fore turned our attention to the characterization of the PbPhLP-3 protein. Previous phyloge-
netic analyses indicates high conservation of PhLP-3 among diverse eukaryotic organisms [10,
28]. Alignment of recently characterized PhLP-3 homologues, ranging from fungi to mam-
mals, coupled with secondary structure prediction, revealed that PbPhLP-3 consists of an N-
terminal helix domain, followed by a thioredoxin-domain and a short C-terminus, an overall
organization characteristic for members of the PhLP family (Fig 4A and 4B) [11]. Notably, the
Fig 3. Knockout strategy for the P. berghei phlp-3 locus. To achieve double-crossover target gene disruption a targeting plasmid was constructed in the parent plasmid
pBS-DHFR [26]. Two fragments, a 512 bp fragment covering the pbphlp-3 5’UTR and a 348 bp fragment corresponding to the 3’UTR were amplified from P. berghei
genomic DNA. The fragments were inserted on each side of the Toxoplasma gondii dhfr/ts selection cassette. The linearized plasmid was transfected into purified P.
berghei schizonts following the procedure described in [26, 27].
https://doi.org/10.1371/journal.pone.0209699.g003
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highest degree of conservation resides within the Trx-domain (Fig 4B). A phylogenetic tree
based on the Trx-domains of characterized PhLP homologues revealed a higher degree of con-
servation between the protozoan parasite and the human PhLP-3 (51%) (HsPhLP-3; alias Trx-
Containing Protein 9 (TXNDC9); Gene ID: 10190) than with those of other lower eukaryotes,
such as Saccharomyces (33%) and Dictyostelium (37%) (Fig 4C).
PbPhLP-3 cloning, expression, purification and redox activity
PbPhLP-3 is a 193 AA protein with a calculated molecular weight of 22.9 kDa (Table 1). We
generated recombinant PbPhLP-3 with an N-terminal 6xHIS tag (Fig 5A). The recombinant
Fig 4. Conservation and organization of PhLP-3 in eukaryotes. A. Alignment of P. berghei with recently characterized PhLP-3 homologs of different species using the
MUSCLE algorithm [29]. Amino acids conserved with P. berghei are highlighted in gray. Predicted domains are indicated above the sequence. The asterisk marks the
single conserved cysteine residue. B. Comparison of structural PhLP-3 organization between different eukaryotes. Inset table shows percent AA identities within
thioredoxin domains. C. Maximum likelihood tree of PhLP-3 sequences with bootstrap replication.
https://doi.org/10.1371/journal.pone.0209699.g004
Redox-active phosducin-like protein 3
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protein was purified using Ni-NTA resin. SDS gel electrophoresis revealed a prominent 24
kDa band, which corresponds to the calculated molecular mass of the tagged PbPhLP-3 (Fig
5B). Additional weaker bands were observed at ~ 50 kDa and ~ 80 kDa, which we hypothesize
to represent disulfide-based multimers of PbPhLP-3 as they collapsed in the presence of reduc-
ing agents dithiothreitol (DTT) and 2-mercaptoethanol (BM), respectively (Fig 5B).
The absence of a discernable [-CXXC-] active site motif in PhLPs gave rise to the assump-
tion that members of the PhLP-family lack redox activity [13]. Yet, several members of the
Trx-superfamily exhibit thiol-based redox activity facilitated by a single cysteine in their
respective active sites (monothiol mechanism), e.g. glutaredoxin 5 (Grx5) in yeast [30, 31]. The
Trx-domain in PbPhLP-3 contains six cysteines (Fig 4A) raising the possibility that the protein
may be redox active. We initially utilized the insulin-reduction assay, which was originally
developed as a simple test for investigating the thiol-based redox activity of thioredoxins [32]
and serves as an indicator for the presence of redox-active cysteines in Trx and Tlps [6, 33]. It
is based on the thiol-dependent reduction of the intermolecular disulfide bridges in insulin by
the small electron donor dithiothreitol (DTT), which leads to the precipitation of the insulin B-
chain. This can be spectrophotometrically measured at 650 nm as an increase in turbidity over
time [34]. We used PbTrx-1 as a positive control and show that it effectively catalyzes insulin
reduction (Figs 5C and S3A) [32, 35]. Recombinant PbPhLP-3 (6 μM) catalyzed insulin reduc-
tion by DTT at an initial rate of 0.0038A min-1. Increasing the PbPhLP-3 concentration to
10 μM resulted in a corresponding increase in the insulin reduction-rate by 1.8 fold demon-
strating that PbPhLP-3 possesses at least one redox-active cysteine. No significant reduction of
insulin by DTT was observed in the absence of enzyme (Fig 5C).
PbPhLP-3 is reduced by the Trx-system
In biological systems, including the malaria parasite, some members of the Trx-superfamily
serve as target-proteins for the cellular Trx-system [36, 37]. To assess whether PbPhLP-3 could
be a potential target for the Trx-system we conducted in vitro Trx-reduction assays utilizing
the endogenous P. berghei Trx-system, which consists of the P. berghei thioredoxin reductase
Fig 5. Cloning, recombinant expression and purification of PbPhLP-3. A. Agarose gel show amplified pbphlp-3 orf from P. berghei cDNA (Lane 1). B. SDS Page
electrophoresis following recombinant PbPhLP-3 purification over a Ni-NTA column. Samples remained either untreated (UT = untreated) or were pretreated with
reducing agents 2-mercaptoethanol (BM) or dithiothretiol (DTT). Solid arrow indicates the recombinant PbPhLP-3 protein incl. HIS-tag. Weak bands in the UT lane
(dashed arrows) designate potential multimers of PbPhLP-3. C. Insulin-based reduction assay [32] shows precipitation of insulin precipitation in the presence of
dithiothreitol (DTT) alone (ctlr) and in the presence of PbTrx-1 or indicated concentrations of PbPhLP-3.
https://doi.org/10.1371/journal.pone.0209699.g005
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(PbTrxR) and PbTrx-1 as previously described [38]. PbPhLP-3 was added to a reaction con-
taining NADPH, and the P. berghei Trx-system. Oxidation of NADPH was followed in a spec-
trophotometer at 340 nm (Fig 6A). NADPH oxidation was observed in the presence of
PbPhLP-3 at an initial rate of 6.5 μM min-1 indicating electron flow from the Trx-system to
PbPhLP-3 (S1A Fig). Following this result, we tested whether PbPhLP-3 accepts electrons
from the flavoenzyme PbTrxR or PbTrx-1, respectively. The experiment was repeated in the
absence of PbTrx-1 and no significant NADPH oxidation was observed. Subsequent addition
of PbTrx-1 to the assay resulted in rapid NADPH oxidation signifying that PbPhLP-3 can
serve as target protein for PbTrx-1 and that it is not a substrate for PbTrxR (Figs 6B and S3A
Fig).
We next determined basic kinetic parameters for the redox reaction between PbTrx-1 and
PbPhLP-3 (Fig 6C). Measurement of initial velocities at varying PbTrx-1 concentrations (0.5–
50 μM) resulted in a hyperbolic curve characteristic for Michaelis-Menten type saturation
kinetics (Fig 6C and Table 2). The KM for PbTrx-1was determined to be 5.82 μM with a kcat of
1.0 min-1. The rate constant for this reaction was calculated as 1.7 x 105 M-1 min-1.
As some Trx-like proteins of Plasmodium, such as thioredoxin-dependent peroxidase-1
(TPx-1), exhibit antioxidant activity [39], we next determined whether recombinant PbPhLP-
3 has the capacity to reduce the reactive oxygen compound tert butyl hydroperoxide (TBHP).
TBHP was added to the Trx-reduction assay and reduction of the compound was observed in
Table 2. Comparison between the kinetic parameters of PbPhLP-3 and HsPhLP-3.
PbPhLP-3 HsPhLP-3
Length (AA) 193 226
Mw (kDa) 22.9 26.5
IP 6.5 5.4
KM [μM] 5.82 6.53
Vmax [μM min-1] 10.05 12.61
kcat [min
-1] 1.00 1.26
kcat/KM [M
-1 min-1] 1.7 x 105 1.9 x 105
https://doi.org/10.1371/journal.pone.0209699.t002
Fig 6. PbPhLP-3 reacts with Trx-system in a Michaelis-Menten type kinetics. A. Outline of the Trx reduction assay which measures the oxidation rate of NADPH at
340 nm. B. Redox activity was detected only in the presence of all three components. C. Graphing initial velocities as a function of varying PbTrx-1 concentrations
shows Michaelis-Menten type kinetics between PbTrx-1 and PbPhLP-3. D. Initial velocities as a function of TBHP concentrations show a linear relationship between
PbPhLP-3 and TBHP. No significant NADPH oxidation was observed in the absence of either PhLP-3 or TBHP OH. E. NADPH oxidation assay over time show that
PbPhLP-3 is reduced by the Trx system (closed circles) but not by the GSH system (open circles). The slope observed in the PbGR/GSH reaction is comparable to the
auto-oxidation rate of NADPH (not shown).
https://doi.org/10.1371/journal.pone.0209699.g006
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the presence of PbPhLP-3, demonstrating that PbPhLP-3 has the capacity to reduce TBHP
(Fig 6D). No significant TBHP reduction was observed in the absence of PbPhLP-3. Increasing
TBHP concentrations resulted in a corresponding linear increase of PbPhLP-3 activity sug-
gesting a non-enzymatic reaction mechanism. It should be noted, that significant NADPH oxi-
dation was only detectable at TBHP concentrations in the millimolar range. In comparison,
the antioxidant protein TPx-1 in P. falciparum effectively reduces TBHP in the micromolar
range [7].
The oxidoreductase glutathione reductase (GR) and the tripeptide glutathione (GSH), con-
stitutes the cellular GSH-system, a second major thiol-based redox system present in most
organisms, including Plasmodium [5]. Cross talk between the Trx- and the GSH-systems
occurs frequently [4, 40] and we therefore assessed whether PbPhLP-3 could also serve as tar-
get for the GSH system. The thiol-reduction assay was repeated utilizing recombinant PbGR/
GSH in place of PbTrxR/PbTrx-1 (Fig 6E). No significant oxidation of NADPH in the pres-
ence or absence of PbPhLP-3 was observed indicating that PbPhLP-3 is not a target for the
GSH-system.
Hypothetical 3D model and site-directed mutagenesis
This is the first report demonstrating redox activity of a PhLP despite the lack of a characteris-
tic active site motif, such as [CXXC]. Examination of the primary sequence shows that
PbPhLP-3 contains six cysteines within its predicted Trx-domain (Fig 7A). Alignment of the
Trx-domains of PbTrx-1 with that of PbPhLP-3 shows that C106 of PbPhLP-3 aligns with the
redox active C33 of PbTrx-1 (Fig 7B). A hypothetical 3D-model using the recently resolved
crystal structure of the Trx-domain of human phosducin-like protein 2 (hPDCL2) [41]) as a
template shows the characteristic Trx-fold, consisting of a central twisted 5-stranded β-pleated
sheet sandwiched by four α-helices (Fig 7C). Notably, the model placed C106 in a position
similar to that of C33 in the active site motif of Plasmodium Trx-1 (PDB ID#2MMN; [42]). We
therefore hypothesized that C106 may facilitate the observed redox activity of PbPhLP-3. To
test this we performed site-directed mutagenesis (Fig 7B) and replaced C106 with serine. The
resulting mutated recombinant protein (PbPhLP-3C106S) expressed and purified as described
for the wild-type protein (PbPhPL-3wt). Repeating the insulin-reduction assay with PbPhLP-
3wt or PbPhLP-3C106S resulted in a significantly reduced insulin reduction rate in the pre-
sense of the mutagenized PbPhLP-3 (S3B Fig). Subsequent testing of PbPhLP-3C106C and
PbPhPL-3wt in the Trx-reduction assay also showed significantly reduced redox-activity with
the mutant PhLP-3C106C (Fig 7D) supporting our hypothesis that C106 plays a significant role
in the redox activity of PbPhLP-3. Notably, this redox active cysteine in the protozoan protein
is conserved throughout the PhLP-3 family (see Fig 4A).
Redox activity is conserved in human PhLP-3
The human and the protozoan PhLP-3 share over 50% sequence identity in the Trx-domain
(Fig 4B), which includes the cysteine identified as redox active in P. berghei. Amino acid align-
ment indicates that the [TWRC] motif identified in PbPhLP-3 is 75% conserved in the human
homolog with tryptophan (W) in the protozoan sequence replaced by phenylalanine (F) in the
human sequence, resulting in a [TFRC] site (Fig 8A). This raised the hypothesis that HsPhLP-
3 may also exhibit redox activity. To test this, we cloned, expressed, and purified HsPhLP-3 fol-
lowing the same protocol described above for PbPhLP-3. HsPhLP-3 is located on chromosome
2 in the human genome and codes for a 226 amino acid protein with a calculated molecular
mass of 27 kDa [15]. The size difference of 5 kDa to the protozoan PhLP-3 is due to a longer
C-terminus (30 amino acids) (see Fig 3A and 3B). An SDS gel of the purified HIS-tagged
Redox-active phosducin-like protein 3
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HsPhLP-3 revealed two prominent bands under non-reducing conditions, one at about 30
kDa and a second at ~ 80 kDa (Fig 8B). The smaller band corresponded to the HIS-tagged
HsPhLP-3. Running the sample in the presence of DTT or 2-mercaptoethanol caused the 80
kDa band to collapse to the 30 kDa, band suggesting that the larger band represents a thiol-
based multimer of recombinant HsPhLP-3.
Following confirmation that recombinant HsPhLP-3 is redox active in the insulin assay
(S3A Fig) we repeated the Trx-reduction assay as described earlier with human Trx-1 (HsTrx-
1) replacing PbTrx-1 and HsPhLP-3 replacing PbPhLP-3, respectively (Fig 8C). We used
PbTrxR as oxidoreductase, since effective reduction of HsTrx-1 by Plasmodium TrxR had
been described previously [4]. Addition of recombinant HsPhLP-3 to a NADPH/PbTrxR/
HsTrx-1 reaction resulted in rapid oxidation of NADPH comparable to the data we collected
Fig 7. Sequence alignment, 3D modeling and site-directed mutagenesis locates redoxactive cysteine in PbPhLP-3. A.
Schematics of PbPhLP-3 showing the predicted domains. The sequence of the thioredoxin domain is shown with all cysteines
underlined. The yellow bar indicates the putative redox active cysteine. Secondary structure prediction within the thioredoxin
domain are also shown. B. Alignment of the PbTrx-1 active site (PDB ID: 2MMN; [42] with the corresponding PbPhLP-3 wt
and mutagenized sequences, respectively. The SDM site is indicated by an arrow. C. Hypothetical model of the Trx-domain of
PbPhLP-3. The recently crystallized Trx-domain of the human phosducin-like protein 2 (hPDCL2) (PDB ID: 3EVI) served as
template [41]. Amino acids of a hypothetical active site are indicated as ball-and-stick representation. D. Trx-reduction assays
comparing redox activities of PbPhLP-3wt and PbPhLP-3C106S.
https://doi.org/10.1371/journal.pone.0209699.g007
Redox-active phosducin-like protein 3
PLOS ONE | https://doi.org/10.1371/journal.pone.0209699 December 31, 2018 10 / 21
for PbPhLP-3, confirming redox activity of HsPhLP-3 (Fig 8C). In a follow-up assay, we
reversed the order of the substrates by starting with an NADPH/HsPhLP-3 mix. The addition
of PbTrxR did not result in significant NADPH oxidation. Subsequent addition of hTrx-1
caused a rapid drop in absorption verifying electron flow from NADPH to PbTrxR to HsTrx-1
to HsPhLP-3 (S3B Fig). We subsequently determined the KM for the reaction between HsTrx-
1 and HsPhLP-3 to be 6.53 μM with a kcat of 1.26 min-1 and a rate constant of 1.9 x 105 M-1
min-1 (Table 2). These data were consistent with those detected in the PbTrx-1/PbPhLP-3
assay and demonstrate not only that redox activity is conserved between protozoan and
human PhLP-3 but also that either protein can serve as a Trx-1 target protein.
Based on our results we propose the following general reaction scheme for PhLP-3:
1. NADPH + H+ + TrxS2 ⇆NADP+ + Trx(SH)2 (TrxR catalyzed)
2. Trx(SH)2 + PhLP-3ox ⇆ TrxS2 + PhLP-3red
Discussion
PhLPs are small Trx-domain containing proteins that are highly conserved in eukaryotes from
yeast to human [10, 11, 28, 43] where they interact with trimeric G-proteins [12] and function
as co-chaperones in the cytosolic protein folding machinery [43]. We recently identified three
novel Trx-like genes in the Plasmodium genome as members of the phosducin-like family of
proteins (PhLPs) [10].
In this study, we characterize the first PhLP of a protozoan organism, the rodent malaria
parasite P. berghei. The complex life cycle of Plasmodium spans two very different host organ-
isms and can be generally divided into blood stages, which take place in the mammalian host,
and mosquito stages, which occur in the mosquito. Gene expression profiles for the parasite
can provide information about the significance of a particular gene for a particular
Fig 8. Redox activity is conserved between Plasmodium and human PhLP-3. A. Sequence alignment around the putative active site (red box) indicates high
conservation, the redoxactive cysteine is highlighted in yellow. Comparison between the hypothetical models of the Plasmodium (red) and the human (blue) PhLP-3
Trx-domains show high structural conservation. Putative active site residues are depicted in Van der Waals mode threonine (green), tryptophan (turquoise),
phenylalanine (purple), arginine (orange), cysteine (yellow). B. SDS Page of PbPhLP-3 purification over a Ni-NTA column. Samples remained either untreated
(UT = untreated) or were pretreated with reducing agents 2-mercaptoethanol (BM) or dithiothretiol (DTT). Solid arrow indicates the size of recombinant HsPhLP-3
protein incl. HIS-tag. The distinct band in the UT lane (dashed arrows) designates a potential multimer of HsPhLP-3. C. Thioredoxin reduction assays show that activity
was detectable only in the presence of all three components.
https://doi.org/10.1371/journal.pone.0209699.g008
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developmental stage. Our transcription data does not indicate any stage-specific expression for
pbphlp-3. We observed constitutive, low-level expression in the blood- as well as in mosquito
stages of P. berghei. Furthermore, the expression profiles of pbphlp-3 in parasites from the
mosquito blood meal and from parasite cultures are comparable. This suggests that pbphlp-3
expression is largely independent of environmental changes, unlike other Trx-related genes,
such as 1-cys prx and tpx-1 [21]. Data from several Plasmodium transcriptome datasets com-
plement these observations and confirm continuous low-level expression of the pbphlp-3 in all
asexual blood stages [16]. This trend continues during parasite development in the mosquito
bloodmeal. It is worth noting that spectra of PbPhLP-3 were detected in proteomics data sets
of Plasmodium sporozoites [19, 44] supporting our hypothesis that the protein is expressed
throughout the entire parasite life cycle.
Our inability to generate pbphlp-3 deficient P. berghei parasites suggests that pbphlp-3 plays
an essential role in this protozoan organism. This is at least the case for the blood stages of the
parasite as those are the principal developmental stages on which genetic manipulation of Plas-
modium is typically performed [26]. Notably, the database for genetically modified rodent
malaria parasites (RMgmDB), which contains information on successful gene disruption in P.
berghei, has no record on a pbphlp-3 knock out parasite [20]. It does, however, contain an
entry describing the successful disruption of pbphlp-2, which does not seem to have any signif-
icant effect on blood stage P. berghei [20].
Low-level phlp expression and lack of response to external stimuli have been reported previ-
ously in other unicellular organisms, including yeast (plp1). Disruption of the plp1 locus in
Saccharomyces (plp1Δ) does not have any effect on the organism [45]. A similar result was
reported for the phlp-3 gene in the ameba Dictyostelium [13]. Interestingly, in contrast to the
results reported here for pbphlp-3 disruption of the phlp-2 gene in either of these organisms
results in a lethal phenotype [13, 45].
Recombinant PbPhLP-3 is the first member of the PhLP family shown to exhibit redox
activity. It was assumed that PhLPs are not redox active due to the lack of a discernable
[CXXC] active site motif that is characteristic for many redox active Trx and Trx-like proteins
[2, 14, 28]. Furthermore, PbPhLP-3 exhibits thiol-based redox activity facilitated in part by a
cysteine located within the highly conserved Trx-domain. Sequence alignment of PbPhLP-3
with the canonical PbTrx-1 aligns the PbTrx-1 [CGPC] active site motif with the sequence
[TWRC] in PbPhLP-3 [10], which includes the redox active cysteine. It is possible that a sec-
ond, distant cysteine is involved in the redox mechanism. The hypothetical 3D model of
PhLP-3 and the VMD graphics analysis suggests that C137 could be surface exposed and in a
close enough proximity to C106 to allow for the formation of a disulfide bridge (S6 Fig).
Although this cysteine seems to be conserved in the mammalian homologues it does not occur
in any of the other analyzed species. We are currently investigating their potential roles in the
redox mechanism. The possible involvement of the other amino acids in the [TWRC]
sequence has yet to be investigated. Alternatively, a monothiol mechanism could be employed
by PhLP-3s as has been described for other members of the Trx-superfamily, e.g. certain glu-
taredoxins [46].
PbPhLP-3 and HsPhLP-3 are reduced by the Trx-system in vitro and exhibit enzyme kinet-
ics similar to those of other recently characterized Trx-like proteins in Plasmodium [7, 38, 47].
This interaction raises the possibility of PhLP-3 being a Trx-target protein in vivo. Supporting
this hypothesis is the lack of activity with the glutathione (GHS) system, which indicates a cer-
tain degree of specificty of PbPhLP-3 for Trx-1. It is, however, possible that the GSH-depen-
dent glutaredoxin (Grx), a Trx-1 relative, has the capacity of reducing PhLP-3 as has been
reported for the Trx-like antioxidant protein (AOP) in Plasmodium [7, 48]. AOP, however, is
not reduced by the Trx-system. Two studies investigated potential Trx-target proteins in
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Plasmodium using an affinity pull-down approach [36, 37]. Neither of the reports detected
PhLPs in their assays. This may be due to low cellular PhLP expression levels, or the fact that
PhLP may be complexed with a cellular chaperonin (see below). Nevertheless, the activity with
the Trx-system introduces the means for PhLP-3 to receive reducing equivalents and thus may
represent a link with the cellular redox system (Fig 9).
Redox active Trx and Tlps have been implemented in antioxidant activity against endoge-
nous and exogenous reactive oxygen (ROS) and reactive nitrogen species (RNS) [49].
Although both PhLP-3 proteins investigated here reduce the oxidative compound TBHP, their
efficiencies were several orders of magnitude lower than that of known antioxidant Tlps, such
as TPx-1 [7]. The fact that it requires TBHP concentrations in the millimolar range to detect a
significant flow of electrons may reflect a low substrate affinity or low enzyme activity by
PhLP-3. It should be noted that other ROS, such as hydroxyl radicals, hydrogen peroxide or
nitric oxide compounds have not yet been tested with PhLP-3 and a higher activity with these
Fig 9. Model showing PhLP-3 as a possible link between the thioredoxin system and the CCT.
https://doi.org/10.1371/journal.pone.0209699.g009
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compounds cannot be excluded. However, considering the low-level pbphlp-3 expression in
vivo and the absence of upregulation in the presence of exogenous stresses in the mosquito
midgut we believe it unlikely for PbPhLP-3 to play a role as an effective antioxidant defense
enzyme in the parasite.
Mammalian PhLPs interact with the Chaperonin Containing TCP-1 (CCT) complex [50,
51], a eukaryotic cytosolic chaperonin central to the folding of actin and tubulin [52]. Recently,
the CCT for the human parasite P. falciparum was isolated and shown to be involved in actin
folding [53]. A significant role of PbPhLP-3 in the fundamental process of actin and/or tubulin
folding could explain the lack of viable parasites in the knock-out attempts. Supporting this
hypothesis are observations that show knockdown of phlp-3 in higher eukaryotes causes severe
phenotypes, primarily affecting cytoskeletal architecture and function [28, 43, 54]. Similarly,
overexpression of mammalian phlp-3 in transgenic Chinese Hamster Ovary cells results in
severe structural defects in monomeric tubulin and actin proteins as well as in microtubules
and microfilaments [50, 54, 55]. Consequently, a role for PhLP-3 as co-chaperone for actin
and tubulin in higher eukaryotes has been proposed [15, 56].
How would redox activity of PhLP-3 fit into the concept of a co-chaperone? Structure anal-
ysis of a rat PhLP-3/CCT complex shows that monomeric PhLP interacts with the apical por-
tion of the barrel-shaped CCT complex [51] (Fig 9). The N-terminal helix domain as well as
the C-terminal region of PhLP are required for binding to the CCT complex, with the Trx-
domain spanning the substrate-binding cavity [15, 51]. While the N-terminal helix domain as
well as the C-terminus are essential for PhLP binding to CCT, the function of the highly con-
served Trx-domain has not been investigated [14, 43, 51]. HsPhLP-3 forms a ternary complex
with CCT substrates actin and tubulin, suggesting an active role in the protein folding process
[15]. PhLP-3 could actively be involved in the folding process. Several members of the Trx-
superfamily that exhibit thiol-based redox reactions function as chaperones. Most prominent
are the Protein Disulfide Isomerases (PDI) in the endoplasmic reticulum (ER) of eukaryotic
cells [57] including the Malaria parasite [58] PDIs facilitate client protein folding via the tem-
porary formation of disulfide bridges, a process known as redox-assisted protein folding[59].
PhLP-3 may function in a similar fashion. Inter- or intramolecular disulfide-bridges formed
during the folding process may be reduced by PhLP-3, which in turn receives electrons from
the Trx system or related redox active protein(s). Alternatively, the redox state of PhLP-3 may
serve to regulate its interactions with the CCT complex and thus entry or exit of client proteins
(Fig 9). Transient association of PhLP with the CCT complex has been hypothesized given that
other proteins, such as the prefoldin, compete for the same binding site on the CCT [43, 60].
PhLP-3 may thus function as “gatekeeper” to regulate entry and exit of CCT client proteins,
specifically actin and tubulin. We are currently investigating the in vivo relevance of the PhLP-
3 redox activity as we hypothesize that PhLP-3 functions as a link between the cellular redox
system and the protein folding machinery.
Conclusion
The characterization of the first protozoan PhLP provides new insights into the functional
capabilities of PhLP-3. It will be important to further investigate the significance of the PhLP-3
redox-activity as it is likely to be fundamentally important for eukaryotic cell biology.
Moreover, the effective reduction of PhLP-3 by the Trx system could represent a link
between the redox regulatory system and the cytosolic protein folding and regulation machin-
ery. Ongoing investigations into the structure-function relationship of PhLPs will give further
insights into the potential protein folding mechanism and regulation of cytoskeletal elements
in eukaryotic cells in general [43] and in protozoan parasite in particular[53].
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Material and methods
Ethics statement
All experimental protocols involving mice, specifically ketamine-induced anesthesia in mice
for mosquito feeds, were approved by the Institutional Animal Care and Use Committee
(IACUC) of Loyola University Chicago (Protocol#1429), which follows the National Institutes
of Health (NIH) guidelines for animal housing and care.
Parasite maintenance and mosquito infections
Plasmodium berghei parasites (ANKA 2.34; originated from the Johns Hopkins Malaria
Research Institute Parasite Core facility [61]) were maintained in female CF-1 mice (Charles
River) for a maximum of four serial passages and regularly passed through Anopheles stephensi
mosquitoes. A. stephensi mosquitoes (Sind-Kasur Nijmegen strain) originated from the
Malaria research group at Radboud University, Nijmegen, Netherlands [62]. Mosquitoes were
reared under standard conditions (30˚C, 80% RH, 12 hrs. light-dark cycle, 5% sucrose solu-
tion). Female mosquitoes (5–10 days post emergence) were used in all experiments. Mosqui-
toes were fed on P. berghei infected mice (10%). Exflagellation (2-4/20x) of parasites was
determined prior to feeding to ascertain parasite maturity. Blood-fed mosquitoes were [62]
maintained at 21˚C and 80% RH to allow for parasite development. Midguts of 40–50 mosqui-
toes were dissected per experimental time point and transferred to Tri-Reagent RT (MRC
gene) for total RNA extraction. Following each feed, we maintained 20 mosquitoes to verify
infection by counting oocysts following mercurochrome stain of dissected midguts nine days
post-infectious blood meal.
RNA extraction and quantitative real-time RT-PCR (RT-qPCR)
Total RNA was extracted from dissected mosquito midguts using Tri-Reagent RT (MRC)
following manufacturer’s instructions. Isolated RNA was treated with DNAse I (Ambion)
and subsequently quantified using a nanodrop 2000 (Thermo). RNA-samples were either
immediately used for cDNA synthesis or flash frozen and stored at -80˚C. cDNA was synthe-
sized from total RNA with the High Capacity RNA-to-cDNA kit (Applied Biosystems) using
random hexamer primers. Sequences of target genes for primer design were acquired from
Plasmodb (plasmodb.org) (S1 Fig). RT-qPCR was performed on a StepOnePlus machine
(Applied Biosystems) using the Fast SYBR Green Master Mix (Applied Biosystems). Each
sample was run in triplicates and yielded highly comparable Ct values (cycle threshold). No
primer dimers were detected and amplicons exhibited optimal efficiencies. To test specificity
all primer pairs were tested on uninfected mouse blood, non-fed and uninfected blood fed
mosquitoes. No amplification products were detected. Expression data was subsequently
analyzed with the StepOne Software v2.2 (Applied Biosystems) and normalized against the
expression of P. berghei 18s rRNA A-Type, which is an established internal standard for
expression analysis in Plasmodium mosquito stages [21, 63, 64]. For analysis of time course
expression data, the ΔΔCt method was applied using the earliest experimental time point
(T1) as reference sample (RQ = 1). The Mann-Whitney U test was conducted on each candi-
date gene from both mosquito-derived and from culture-derived parasites. Significance was
assessed at p<0.1 due to the low sample sizes. The non-parametric Mann-Whitney U test
was the appropriate statistical analytical approach to use on this dataset due to the violated
assumptions of independence in the data and the low and unbalanced sample sizes in gene
expression collected at 3, 6, 12, and 24 hours. Statistical analyses were performed in the R-
language environment.
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Knock-out construct, parasite preparation, transfection, and selection
strategies
A targeting vector was constructed in plasmid pBS-DHFR. A 516 bp fragment comprising the
5’ flanking sequence and a 348 bp fragment of the 3’ flanking sequence of pbphlp-3 were ampli-
fied from P. berghei genomic DNA (S2 Fig). The 5’ fragment was inserted using the ApaI and
HindIII restriction sites immediately upstream of the dhfr/ts cassette while the 3’ fragment was
inserted into the downstream BamH1 and XbaI restriction sites. The dhfr/ts cassette confers
resistance to the antiparasitic compound pyrimethamine. Following sequence verification, the
completed pbphlp-3 KO targeting construct was linearized and purified and then transfected
into cultured and purified P. berghei schizonts as described previously in [24, 27]. The attempt
to generate a pbphlp-3 knockout line was repeated three times.
Cloning, site-directed mutagenesis, expression, and purification of
recombinant PbPhLP-3, PhLP-3C106S, and HsPhLP-3
Gene-specific primers for pbphlp-3 (Plasmodb ID: PBANKA_1204800, NCBI GeneID#:
3423045) and hsphlp-3 (aliases: APACD, TXNDC9; Gene ID# 10190) were generated according
to sequence information on PlasmoDB and NCBI, respectively (S2 Fig). PCRs were performed
using the following conditions: 35 cycles of 95˚C for 30 s, 54˚C for 1 min, and 63˚C for 45 s. Fol-
lowing sequence verification, the pbphlp-3 cds was cloned into the bacterial pQE30 expression
vector (Qiagen) which introduced a 6xHIS tag at the N-terminus of the recombinant protein.
The pbphlp-3 expression plasmid was transformed into E. coli M15 cells (Qiagen). Human
PhLP-3 expression using pQE30 did not work. The hsphlp-3 coding sequence was therefore
cloned into the bacterial pRSET-A expression vector (Thermo Fisher), which also provides an
N-terminal 6xHIS tag. The resulting plasmid was then transformed into BL21(DE3) expression
cells. To generate the mutated pbphlp-3 we utilized the Phusion Site-Directed Mutagenesis kit
(Thermo Fisher). Using two phosphorylated primers, one containing the cysteine to serine
mutation, we modified and amplified the entire pQE30-pbphlp-3 plasmid, which now coded for
PhLPC106S. Protein expression was induced (1 mM IPTG) and bacteria were harvested after a
5 hours incubation period at 37˚C. Recombinant proteins were purified using Ni-NTA resin
(Thermo Scientific). The purity of the recombinant proteins was assessed via SDS-PAGE. Pro-
tein concentrations were determined using the Qubit fluorometer (Invitrogen).
Enzyme assays
All enzymatic assays were carried out in 1 ml volume at 25˚C using a Genesys6 UV-Vis spectro-
photometer (Thermo Fisher). The insulin reduction assay was conducted as described [32]. Enzy-
matic activity of the recombinant protein was determined by adding varying amounts of purified
PbPhLP-3, HsPhLP-3 or PbTrx-1 to a reaction mixture containing bovine insulin (44 μg ml-1)
and DTT (1 mM) in a potassium phosphate buffer (100 mM potassium phosphate, 2 mM EDTA,
pH 7.4). The reduction of the insulin disulfide bonds was monitored as an absorbance increase
over time at 650 nm. The coupled enzymatic assays utilizing thioredoxin reductase/thioredoxin
were conducted as previously described [4, 48]. Briefly, oxidation of NADPH was followed as an
absorption decrease at 340 nm. All assays were performed at RT in assay buffer containing 100
mM KH2PO4, 2 mM EDTA, pH 7.4, 200 μM NADPH (ε340 nm = 6.22 mM-1cm-1), and 20 μM
PbTrx-1 (S4 Fig). Each initial reaction was started with PbTrxR and the decrease of absorption at
340 nm was monitored during the linear phase. Initial velocities and kinetic values for each reac-
tion were determined using the VISIONlite (Thermo Fisher) software. Enzyme kinetics were cal-
culated using global curve fit in the Enzyme Kinetics Module of Sigma Plot 12.0.
Redox-active phosducin-like protein 3
PLOS ONE | https://doi.org/10.1371/journal.pone.0209699 December 31, 2018 16 / 21
Comparative modeling
The hypothetical models of PbPhLP-3 and HsPhLP-3 were generated using Swiss Model
(http://swissmodel.expasy.org; [65]). The crystal structure of the Trx-fold domain of the
human PhLP-2 (PDB ID: 3EVI; [41]) was selected as the template from the RCSB Protein Data
Bank (http://www.rcsb.org/). The models were visualized using the Visual Molecular Dynam-
ics (VMD) molecular graphics program [66].
Supporting information
S1 Fig. PbPhLP-3 translation map and primer positions.
(TIF)
S2 Fig. Primer sequences.
(TIF)
S3 Fig. Insulin assays using PbTrx-1, PbPhLP-3, HsPhLP-3, BSA and PbPhLP-3Wt,
PbPhLP-3C106S. Oxidation of insulin over time in the presence of A. PbTrx-1, PbPhLP-3, and
HsPhLP-3 and B. PbPhLP-3WT and PbPhLP-3C106S, respectively. BSA was used as negative
control.
(TIF)
S4 Fig. Thioredoxin-reduction assays determine order of electron transport. The oxidation
of NADPH was measured as a decrease in absorption at 340 nm over time. A. PbPhLP-3 Reac-
tion 1 (filled circles) was started with a mixture of NADPH and oxidized PbTrx-1. PbTrxR was
added (dashed arrow) and the reduction of PbTrx-1 was allowed to come to completion. Oxi-
dized PbPhLP-3 was then added to the mixture and continuous reduction of NADPH was
observed. Reaction 2 (open circles) was started with a mixture of NADPH and oxidized
PbPhLP-3. PbTrxR was added (dashed arrow) and reduction of NADPH was measured. After
3 min oxidized PbTrx-1 was added and reduction of NADPH was observed. B. The same
experimental approach was used with human Trx-1 and HsPhLP-3 in place of PbTrx-1 and
PbPhLP-3, respectively.
(TIF)
S5 Fig. Conservation of PhLP-3 among murine and human Plasmodium species. Multiple
sequence alignment (Clustal W) of putative PhLP-3 proteins of Plasmodium species P. berghei
(PB), P. chabaudi (PC), P. falciparum (PF), P. knowlesi (PKH), P. vivax (PVX) and P. yoelii
(PY) (“�” = Identical; “:” = high similarity; “.” = low similarity). The arrow marks the redox
active cysteine describe in this work. The table indicates percent identities.
(TIF)
S6 Fig. 3D model of PbPhLP-3 showing hypothetical intramolecular disulfide bridge for-
mation with in the thioredoxin domain. The Visual Molecular Dynamics (VMD) molecular
graphics program calculated possible intramolecular disulfide bridge formation within
PbPhLP-3. Shown is a energetically possible disulfide bridge between C106 and C137.
(TIF)
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